Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program.
Ther Adv Med Oncol
; 14: 17588359221103206, 2022.
Article
in En
| MEDLINE
| ID: mdl-35720834
Full text:
1
Database:
MEDLINE
Language:
En
Journal:
Ther Adv Med Oncol
Year:
2022
Type:
Article
Affiliation country:
Austria